乳腺癌幸存者中心肌梗死风险的辐射剂量-反应关系
该嵌套病例对照研究纳入1970至2009年间治疗的乳腺癌幸存者,183例心肌梗死患者按年龄和诊断日期与对照1:1匹配。心肌梗死发生率随平均全心脏剂量线性增加(每Gy超额率比6.4%,95%CI 1.3%-16.0%),平均全心脏剂量≥20 Gy者心肌梗死率是未放疗者的3.4倍(95%CI 1.5-7.6)。结论认为降低平均全心脏剂量预期有助于改善乳腺癌幸存者心血管健康。
要点
- 心肌梗死发生率随平均全心脏剂量线性增加,每Gy超额率比6.4%(95%CI 1.3%-16.0%)。
- 平均全心脏剂量≥20 Gy者心肌梗死率是未放疗者的3.4倍(95%CI 1.5-7.6)。
- 年轻女性超额率比更高,<45岁24.2%/Gy vs ≥50岁2.5%/Gy(交互作用P=.054,临界显著)。
核心结论
- 乳腺癌放疗后心肌梗死发生率随平均全心脏剂量线性增加。
- 降低平均全心脏剂量预期有助于改善乳腺癌幸存者心血管健康。
研究设计与样本
- 在1970至2009年间治疗的乳腺癌幸存者队列中开展嵌套病例对照研究。
- 病例为183例乳腺癌后以心肌梗死为首发心脏病的患者,每例按年龄和乳腺癌诊断日期匹配1名对照。
- 治疗和心血管危险因素信息从医疗和放疗记录中提取。
- 每名女性的心脏剂量通过使用现代三维计算机断层扫描计划在典型患者CT扫描上重建其方案来估算。
主要发现
- 病例和对照的乳腺癌诊断中位年龄为50.2岁(四分位距45.7-54.7)。
- 心肌梗死中位时间为13.6年(四分位距9.9-18.1)。
- 中位平均全心脏剂量为8.9 Gy(范围0.3-35.2 Gy)。
- 心肌梗死率随平均全心脏剂量增加呈线性增加,每Gy超额率比为6.4%(95%CI 1.3%-16.0%)。
- 接受平均全心脏剂量≥20 Gy的患者心肌梗死率是未放疗患者的3.4倍(95%CI 1.5-7.6)。
关键数值与推荐
- 年轻女性超额率比更高,临界显著:<45岁为24.2%/Gy,≥50岁为2.5%/Gy,交互作用P=.054。
- 全心脏剂量-体积参数未显著改变剂量-反应关系。
临床怎么用
- 原文未据此给出推荐。
局限性
- 年轻女性超额率比更高的结果为临界显著(交互作用P=.054)。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Previous reports suggest that radiation therapy for breast cancer (BC) can cause ischemic heart disease, with the radiation-related risk increasing linearly with mean whole heart dose (MWHD). This study aimed to validate these findings in younger BC patients and to investigate additional risk factors for radiation-related myocardial infarction (MI). METHODS AND MATERIALS: A nested case-control study was conducted within a cohort of BC survivors treated during 1970 to 2009. Cases were 183 patients with MI as their first heart disease after BC. One control per case was selected and matched on age and BC diagnosis date. Information on treatment and cardiovascular risk factors was abstracted from medical and radiation charts. Cardiac doses were estimated for each woman by reconstructing her regimen using modern 3-dimensional computed tomography planning on a typical patient computed tomography scan. RESULTS: Median age at BC of cases and controls was 50.2 years (interquartile range, 45.7-54.7). Median time to MI was 13.6 years (interquartile range, 9.9-18.1). Median MWHD was 8.9 Gy (range, 0.3-35.2 Gy). MI rate increased linearly with increasing MWHD (excess rate ratio [ERR] per Gy, 6.4%; 95% confidence interval, 1.3%-16.0%). Patients receiving ≥20 Gy MWHD had a 3.4-fold (95% confidence interval, 1.5-7.6) higher MI rate than unirradiated patients. ERRs were higher for younger women, with borderline significance (ERR<45years, 24.2%/Gy; ERR≥50years, 2.5%/Gy; Pinteraction = .054). Whole heart dose-volume parameters did not modify the dose-response relationship significantly. CONCLUSIONS: MI rate after radiation for BC increases linearly with MWHD. Reductions in MWHD are expected to contribute to better cardiovascular health of BC survivors.
引用
- Jacobse JN, Duane FK, Boekel NB, et al. Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors. Int J Radiat Oncol Biol Phys. 2018. PMID: 30385276. doi:10.1016/j.ijrobp.2018.10.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。